CORONARY ARTERY CALCIUM IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA RECEIVING STANDARD LIPID-LOWERING THERAPY

被引:0
|
作者
Sheth, Samip
Rader, Daniel
Jacoby, Douglas
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
113
引用
收藏
页码:S39 / S39
页数:1
相关论文
共 50 条
  • [21] Attenuated response of myocardial flow reserve to lipid-lowering therapy with atorvastatin in patients with familial hypercholesterolemia.
    Ishida, Y
    Tsushima, M
    Fukuchi, K
    Miyake, Y
    Sagoh, M
    Oka, H
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 54P - 54P
  • [22] LIPID LOWERING THERAPY WITH STATINS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Korneva, V. A.
    Kuznetsova, T. Yu
    Tihova, G. P.
    KARDIOLOGIYA, 2019, 59 (03) : 27 - 35
  • [23] GENETIC MUTATIONS AND LIPID-LOWERING RESPONSE IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Kim, H.
    Lee, S. H.
    ATHEROSCLEROSIS, 2020, 315 : E97 - E98
  • [24] Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy
    Raal, Frederick J.
    Pilcher, Gillian J.
    Panz, Vanessa R.
    van Deventer, Hendrick E.
    Brice, Brigitte C.
    Blom, Dirk J.
    Marais, A. David
    CIRCULATION, 2011, 124 (20) : 2202 - 2207
  • [25] Familial Hypercholesterolemia in Children and Safety of Early Lipid-Lowering Treatment
    Bellunghi, Maria Sol
    Miname, Marcio
    Jannes, Cinthia E.
    Silva, Pamela R.
    Pereira, Alexandre
    Chacra, Ana Paula
    Salgado, Wilson
    Santos, Raul D.
    Rocha, Viviane Z.
    CIRCULATION, 2017, 136
  • [26] Tolerability and effects of high doses acipimox as additional lipid-lowering therapy in familial hypercholesterolemia
    Stuyt, PMJ
    Kleinjans, HAJ
    Stalenhoef, AFH
    NETHERLANDS JOURNAL OF MEDICINE, 1998, 53 (05): : 228 - 233
  • [27] How common is rhabdomyolysis in patients receiving lipid-lowering therapy?
    Paul S Phillips
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 : 130 - 131
  • [28] REGRESSION OF CORONARY ATHEROSCLEROSIS BY COMBINED LDL-APHERESIS AND LIPID-LOWERING DRUG-THERAPY IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA - A MULTICENTER STUDY
    TATAMI, R
    INOUE, N
    ITOH, H
    KISHINO, B
    KOGA, N
    NAKASHIMA, Y
    NISHIDE, T
    OKAMURA, K
    SAITO, Y
    TERAMOTO, T
    YASUGI, T
    YAMAMOTO, A
    GOTO, Y
    ATHEROSCLEROSIS, 1992, 95 (01) : 1 - 13
  • [29] Flow common is rhabdomyolysis in patients receiving lipid-lowering therapy?
    Phillips, PS
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2005, 2 (03): : 130 - 131
  • [30] Hypercholesterolemia - Is lipid-lowering worthwhile for older patients
    Deedwania, PC
    GERIATRICS-US, 2000, 55 (05): : 22 - +